Biological correlates of HIV-1 heterosexual transmission

AIDS

Volumn 11, Issue 9, 1997, Pages 1089-1094

  Fiore, José Ramon ^a,b   Zhang, Yi Jun ^a   Björndal, Åsa ^a   Di Stefano, Mariantonietta ^a,b   Angarano, Gioacchino ^b   Pastore, Giuseppe ^b   Fenyö, Eva Maria ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Heterosexual transmission; HIV 1; HIV 1 biological phenotype; Neutralizing antibodies; Viral load

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; SEROCONVERSION; SEXUAL TRANSMISSION; VIRUS TRANSMISSION;

CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; NEUTRALIZATION TESTS; PHENOTYPE; RNA, VIRAL; SEXUALITY; VIRUS REPLICATION;

EID: 0030905566     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199709000-00002     Document Type: Article

References (19)

1. Quinn IC: Epidemiologic trends in HIV infection. Curr Opin Infect Dis 1991, 5:189-200.
2. Krieger JN, Coombs RW, Collier NC, et al.: Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral therapy. J Infect Dis 1991, 163:386-388.
3. Hanin J, Mandelbrot L, Henrion R, Pradinaud R, Couland JP, Montagner L: Virus excretion in the cervicovaginal secretions of pregnant and non pregnant women. J Aquir Immune Defic Syndr 1993, 6:72-75.
4. Carael M, Van De Perre PH, Lepage PH, et al.: Human immunodeficiency virus transmission among heterosexual couples in Central Africa. AIDS 1988, 2:201-205.
5. European Study Group: Risk factors for male to female transmission of HIV. BMJ 1989, 298:411-415.
6. Padian NS, Shiboski SC, Jewell NP: The effect of number of exposures on the risk of heterosexual HIV transmission. J Infect Dis 1989, 161:883-887.
7. Plummer FA, Simonsen JN, Cameron DW, et al.: Cofactors in male-to-female transmission of human immunodeficiency virus type-1. J Infect Dis 1991, 163:233-239.
8. Basset MT, Latii AS, Katzenstein DA, Emmanuel JC: Sexual behaviour and risk factors for HIV infection in a group of male factory workers who donated blood in Harare, Zimbawe. J Acquir Immune Defic Syndr 1992, 5:556-559.
9. Musicco M, Lazzarin A, Nicolosi A, et al.: Antiretroviral treatment of men infected with human immunodeficiency virus type-1 reduces the incidence of heterosexual transmission. Arch Intern Med 1994, 154:1971-1976.
10. Fenyö EM, Fiore JR, Karlsson A, Albert J, Scarlatti G: Biological phenotypes of HIV-1 in pathogenesis and transmission. Antib Chemother 1994, 46:18-24.
11. Fiore JR, Jansson M, Scarlatti G, et al.: Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission. AIDS 1993, 7:29-31.
12. Fiore JR, Calabró ML, Angarano G, et al.: HIV-1 variability and progression to AIDS: a longitudinal study. J Med Virol 1990, 32:252-256.
13. Albert J, Abrahamsson B, Nagy K, et al.: Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 1990, 4:107-112.
14. Albert J, Björling E, von Gegerfelt A, Thorstensson R, Zhang J, Fenyö FM: Antigen detection is a reliable method for evaluating HIV/SIV neutralization assays. AIDS Res Hum Retrovirol 1993, 6:501-504.
15. Fang G, Burger H, Grimson R, et al.: Maternal plasma human immunodeficiency virus type-1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 1995, 92:12100-12104.
16. Scarlatti G, Albert J, Rossi P, et al.: Mother-to-child transmission of human immunodeficiency virus type-1: correlation with neutralizing antibodies against primary HIV-1 isolates. J Infect Dis 1993, 168:207-210.
17. Scarlatti G, Hodora V, Rossi P, et al.: Transmission of human immunodeficiency virus type-1 (HIV-1) from mother-to-child correlates with viral phenotype. Virology 1993, 197:624-629.
18. Connor EM, Sperling RS, Gelber R, et al.: Reduction of maternal-infant transmission of human immunodeficiency virus type-1 with zidovudine treatment. N Engl J Med 1994, 331:1173-1180.
19. Von Gegerfelt A, Albert J, Morfeldt-Manson L, Broliden K, Fenyö EM: Isolate-specific neutralizing antibodies in patients with progressive HIV-1 related disease. Virology 1991, 185:162-181.